Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48

被引：0
|
作者：
Tianzhuo Zhang
Qin Fang
Ping Liu
Ping Wang
Cheng Feng
Jishi Wang
机构：
[1] Guizhou Medical University,Department of Clinical Medical School
[2] Affiliated Hospital of Guizhou Medical University,Department of Hematology
[3] Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre,Department of Pharmacy
[4] Affiliated Hospital of Guizhou Medical University,undefined
来源：
Journal of Translational Medicine | / 20卷
关键词：
Acute myeloid leukemia; Heme oxygenase 1; Natural killer cells; CD48; Sirt1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors
    Marin, Virna
    Pizzitola, Irene
    Agostoni, Valentina
    Attianese, Greta Maria Paola Giordano
    Finney, Helene
    Lawson, Alastair
    Pule, Martin
    Rousseau, Raphael
    Biondi, Andrea
    Biagi, Ettore
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (12): : 2144 - 2152
  • [42] IL-1β-releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from CD34+ precursors
    Vitale, Chiara
    Ambrosini, Paolo
    Montaldo, Elisa
    Ballerini, Filippo
    Moretta, Lorenzo
    Mingari, Maria Cristina
    HAEMATOLOGICA, 2015, 100 (02) : E42 - E45
  • [43] Combined use of human iPSC-derived natural killer cells with macrophages and anti-CD47 blockade to improve killing of acute myeloid leukemia
    Goldenson, Benjamin
    Fierro, Manuel
    Pouyanfard, Somayeh
    Kaufman, Dan S.
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Bone marrow infiltrated natural killer cells predicted the anti-leukemia activity of MCL1 or BCL2 inhibitors in acute myeloid leukemia
    Dai, Yu-Jun
    He, Si-Yuan
    Hu, Fang
    Li, Xue-Ping
    Zhang, Jian-Ming
    Chen, Si-Liang
    Zhang, Wei-Na
    Sun, Hai-Min
    Wang, Da-Wei
    MOLECULAR CANCER, 2021, 20 (01)
  • [45] Bone marrow infiltrated natural killer cells predicted the anti-leukemia activity of MCL1 or BCL2 inhibitors in acute myeloid leukemia
    Yu-Jun Dai
    Si-Yuan He
    Fang Hu
    Xue-Ping Li
    Jian-Ming Zhang
    Si-Liang Chen
    Wei-Na Zhang
    Hai-Min Sun
    Da-Wei Wang
    Molecular Cancer, 20
  • [46] Lentivirally and Alpharetrovirally Engineered CD19specific Chimeric Antigen Receptor Natural Killer Cells are Highly Cytotoxic against Acute Lymphoblastic Leukemia
    Bexte, Tobias
    Mueller, Stephan
    Gebel, Veronika
    Kalensee, Franziska
    Stolzenberg, Eva
    Hartmann, Jessica
    Koehl, Ulrike
    Schambach, Axel
    Winfried, Wels S.
    Modlich, Ute
    Ullrich, Evelyn
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 262 - 262
  • [47] Ex vivo generation of clinical relevant amounts of human natural killer cells from CD34+haematopoietic progenitor cells for immunotherapy against acute myeloid leukaemia
    Spanholtz, J.
    Tordoir, M.
    Groenewegen, D.
    de Witte, T.
    Dolstra, H.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S159 - S159
  • [48] Overexpression of MYCT1 Inhibits Proliferation and Induces Apoptosis in Human Acute Myeloid Leukemia HL-60 and KG-1a Cells in vitro and in vivo
    Fu, Shuang
    Fu, Yu
    Chen, Fang
    Hu, Yanping
    Quan, Bi
    Zhang, Jihong
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [49] Expansion of natural killer cells with lyticactivity against acute myeloid leukemia blasts under good manufacturing practice conditions. A possible new strategy for allografted patients?
    Torelli, G. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 220 - 221
  • [50] High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
    Mueller, Stephan
    Bexte, Tobias
    Gebel, Veronika
    Kalensee, Franziska
    Stolzenberg, Eva
    Hartmann, Jessica
    Koehl, Ulrike
    Schambach, Axel
    Wels, Winfried S.
    Modlich, Ute
    Ullrich, Evelyn
    FRONTIERS IN IMMUNOLOGY, 2020, 10
12345